Background Large population-based studies give insight into the prognosis and treatment
outcomes of patients with pancreatic neuroendocrine tumors (pNETs). Therefore, we provide …

Background There are currently 2 Tumour-Node-Metastasis (TNM) staging systems for
pancreatic neuroendocrine tumours (p-NETs)-European Neuroendocrine Tumour Society …

Background & Aims: Prediction of biological behavior in pancreatic endocrine tumors (PET)
is difficult on histologic criteria alone. The aim of this study was to characterize PET gene …

Gastroenteropancreatic neuroendocrine tumors are rare neoplasms; past decades have
seen limited research channeled into this area. Recently, 2 placebo-controlled phase III …

Background Conflicting data exist on predictors of nodal metastases and their impact on
survival in patients with pancreatic neuroendocrine tumors (PNETs). We aim to identify …

Background Pancreatic neuroendocrine tumours (pNETs) are a rare and heterogeneous
group of tumours with an increasing incidence. Current staging criteria for pNETs remain …

Pancreatic neuroendocrine neoplasms (PanNENs) are rare neoplasms arising from islets of
the Langerhans in the pancreas. They can be divided into two groups, based on peptide …

Management of advanced pancreatic neuroendocrine tumors (PNETs) is challenging.
Chemotherapy has remained for decades the only validated therapeutic option, with …

Introduction: To address the issue of limited data on and inconsistent findings for genetic
alterations in pancreatic neuroendocrine tumors (pNETs), we analyzed sequences of known …

Patients with pancreatic neuroendocrine tumors (PNET) commonly develop advanced
disease and require systemic therapy. However, treatment options remain limited, in part …